CLDX - CIK 0000744218
Celldex Therapeutics, Inc. has filed 1,268 documents with the SEC between 1995 and 2026. The most frequent type is insider trade (458 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| Insider trade | 4 | 2024-06-17 | 2024-06-13 |
| Insider sale notice | 144 | 2024-06-14 | - |
| Insider sale notice | 144 | 2024-06-14 | - |
| Employee stock plan | S-8 | 2024-06-14 | - |
| Major company event | 8-K | 2024-06-14 | 2024-06-13 |
| Insider trade | 4 | 2024-06-13 | 2024-06-11 |
| Insider trade | 4 | 2024-06-11 | 2024-06-07 |
| Insider trade | 4 | 2024-06-11 | 2024-06-07 |
| Insider sale notice | 144 | 2024-06-07 | - |
| Insider sale notice | 144 | 2024-06-07 | - |
| Insider trade | 4 | 2024-06-07 | 2024-06-05 |
| Insider trade | 4 | 2024-06-05 | 2024-06-03 |
| Insider trade | 4 | 2024-06-05 | 2024-06-03 |
| Insider trade | 4 | 2024-06-05 | 2024-06-03 |
| Insider sale notice | 144 | 2024-06-03 | - |
| Insider sale notice | 144 | 2024-06-03 | - |
| Insider trade | 4 | 2024-06-03 | 2024-05-30 |
| Insider trade | 4 | 2024-06-03 | 2024-05-30 |
| Insider trade | 4 | 2024-06-03 | 2024-05-30 |
| Insider trade | 4 | 2024-06-03 | 2024-05-30 |
| Insider sale notice | 144 | 2024-05-30 | - |
| Insider sale notice | 144 | 2024-05-30 | - |
| Insider sale notice | 144 | 2024-05-30 | - |
| Insider sale notice | 144 | 2024-05-30 | - |
| Quarterly report | 10-Q | 2024-05-06 | 2024-03-31 |
| Major company event | 8-K | 2024-05-06 | 2024-05-06 |
| Annual report to shareholders | ARS | 2024-04-25 | 2023-12-31 |
| Proxy statement | DEF 14A | 2024-04-25 | 2024-06-13 |
| Major company event | 8-K | 2024-03-01 | 2024-02-28 |
| Prospectus supplement | 424B5 | 2024-03-01 | - |
| Prospectus supplement | 424B5 | 2024-02-28 | - |
| Annual report | 10-K | 2024-02-26 | 2023-12-31 |
| Major company event | 8-K | 2024-02-26 | 2024-02-26 |
| Prospectus supplement | 424B5 | 2024-02-26 | - |
| Insider trade | 4 | 2024-02-15 | 2024-02-13 |
| Passive ownership stake | SC 13G | 2024-02-14 | - |
| Passive ownership stake | SC 13G | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake | SC 13G | 2024-02-13 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-13 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-09 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-08 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-01-26 | - |
| Insider trade | 4 | 2024-01-04 | 2024-01-02 |
| Passive ownership stake | SC 13G | 2023-11-20 | - |